These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26075703)

  • 1. Angiotensin-(1-7) administration benefits cardiac, renal and progenitor cell function in db/db mice.
    Papinska AM; Mordwinkin NM; Meeks CJ; Jadhav SS; Rodgers KE
    Br J Pharmacol; 2015 Sep; 172(18):4443-4453. PubMed ID: 26075703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-(1-7) administration reduces oxidative stress in diabetic bone marrow.
    Mordwinkin NM; Meeks CJ; Jadhav SS; Espinoza T; Roda N; diZerega GS; Louie SG; Rodgers KE
    Endocrinology; 2012 May; 153(5):2189-97. PubMed ID: 22434085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term administration of angiotensin (1-7) prevents heart and lung dysfunction in a mouse model of type 2 diabetes (db/db) by reducing oxidative stress, inflammation and pathological remodeling.
    Papinska AM; Soto M; Meeks CJ; Rodgers KE
    Pharmacol Res; 2016 May; 107():372-380. PubMed ID: 26956523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism.
    Gohlke P; Pees C; Unger T
    Hypertension; 1998 Jan; 31(1 Pt 2):349-55. PubMed ID: 9453327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin 1-7 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity.
    Mori J; Patel VB; Ramprasath T; Alrob OA; DesAulniers J; Scholey JW; Lopaschuk GD; Oudit GY
    Am J Physiol Renal Physiol; 2014 Apr; 306(8):F812-21. PubMed ID: 24553436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boldine improves endothelial function in diabetic db/db mice through inhibition of angiotensin II-mediated BMP4-oxidative stress cascade.
    Lau YS; Tian XY; Mustafa MR; Murugan D; Liu J; Zhang Y; Lau CW; Huang Y
    Br J Pharmacol; 2013 Nov; 170(6):1190-8. PubMed ID: 23992296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of cyclic GMP production via AT2 and B2 receptors in the pressure-overloaded aorta after banding.
    Hiyoshi H; Yayama K; Takano M; Okamoto H
    Hypertension; 2004 Jun; 43(6):1258-63. PubMed ID: 15123575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin Type 2 and Mas Receptor Activation Prevents Myocardial Fibrosis and Hypertrophy through the Reduction of Inflammatory Cell Infiltration and Local Sympathetic Activity in Angiotensin II-Dependent Hypertension.
    Castoldi G; Carletti R; Ippolito S; Stella A; Zerbini G; Pelucchi S; Zatti G; di Gioia CRT
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azilsartan ameliorates diabetic cardiomyopathy in young db/db mice through the modulation of ACE-2/ANG 1-7/Mas receptor cascade.
    Sukumaran V; Tsuchimochi H; Tatsumi E; Shirai M; Pearson JT
    Biochem Pharmacol; 2017 Nov; 144():90-99. PubMed ID: 28789938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of Angiotensin (1-7)-Mediated Signaling Preserves Endothelial Function Through Reducing Oxidative Stress in Diabetes.
    Zhang Y; Liu J; Luo JY; Tian XY; Cheang WS; Xu J; Lau CW; Wang L; Wong WT; Wong CM; Lan HY; Yao X; Raizada MK; Huang Y
    Antioxid Redox Signal; 2015 Oct; 23(11):880-92. PubMed ID: 25867182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of simultaneous blockade of AT1 and AT2 receptors on the NFkappaB pathway and renal inflammatory response.
    Esteban V; Ruperez M; Vita JR; López ES; Mezzano S; Plaza JJ; Egido J; Ruiz-Ortega M
    Kidney Int Suppl; 2003 Oct; (86):S33-8. PubMed ID: 12969125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
    Siragy HM; Carey RM
    J Clin Invest; 1997 Jul; 100(2):264-9. PubMed ID: 9218502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.
    Haddad G; Amiri F; Garcia R
    Regul Pept; 1997 Jan; 68(2):111-7. PubMed ID: 9110382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis.
    Kurisu S; Ozono R; Oshima T; Kambe M; Ishida T; Sugino H; Matsuura H; Chayama K; Teranishi Y; Iba O; Amano K; Matsubara H
    Hypertension; 2003 Jan; 41(1):99-107. PubMed ID: 12511537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin 1-7 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db/db mice by reducing lipotoxicity and inflammation.
    Mori J; Patel VB; Abo Alrob O; Basu R; Altamimi T; Desaulniers J; Wagg CS; Kassiri Z; Lopaschuk GD; Oudit GY
    Circ Heart Fail; 2014 Mar; 7(2):327-39. PubMed ID: 24389129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of brain angiotensin II (type 2) receptors and nitric oxide in the renal sympathoinhibitory response to acute volume expansion in conscious rats.
    Abdulla MH; Johns EJ
    J Hypertens; 2017 Feb; 35(2):338-347. PubMed ID: 27820727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of AT1 and AT2 angiotensin receptor antagonists in angiotensin II-infused rats.
    Li JS; Touyz RM; Schiffrin EL
    Hypertension; 1998 Jan; 31(1 Pt 2):487-92. PubMed ID: 9453350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of angiopoietin-1 increases CD133+/c-kit+ cells and reduces myocardial apoptosis in db/db mouse infarcted hearts.
    Zeng H; Li L; Chen JX
    PLoS One; 2012; 7(4):e35905. PubMed ID: 22558265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II type 1 receptor blockade restores angiotensin-(1-7)-induced coronary vasodilation in hypertrophic rat hearts.
    Souza ÁP; Sobrinho DB; Almeida JF; Alves GM; Macedo LM; Porto JE; Vêncio EF; Colugnati DB; Santos RA; Ferreira AJ; Mendes EP; Castro CH
    Clin Sci (Lond); 2013 Nov; 125(9):449-59. PubMed ID: 23718715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency.
    Yagi S; Aihara K; Ikeda Y; Sumitomo Y; Yoshida S; Ise T; Iwase T; Ishikawa K; Azuma H; Akaike M; Matsumoto T
    Circ Res; 2008 Jan; 102(1):68-76. PubMed ID: 17967781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.